Healthcare technology company Medtronic has brought in its Adaptive Deep Brain Stimulation (aDBS) system, a device that can help treat patients with Parkinson’s disease.

India is home to about 10 per cent of the global Parkinson’s disease burden – a public health concern, a note from the company said. Parkinson’s is a progressive neurological condition that can, over time, make routine activities such as walking, writing or holding everyday objects more difficult.

While movement-related challenges are often the most visible, the condition can also influence other aspects of daily living, including communication, sleep and overall well‑being, it explained.

Treatment options

Treatment pathways are adjusted based on individual needs and clinical assessment by specialists, and they include options like DBS that involve “manual adjustment of stimulation levels throughout the day, usually managed by patients or caregivers,” it explained.

Medtronic’s aDBS uses BrainSense technology, approved by the US Food and Drug Administration, it added. “DBS uses a small, pacemaker-like device, placed under the skin of the chest, to send electronic signals to an area in the brain that controls movement. To give you relief, these signals block some of the brain messages that cause the movement symptoms of Parkinson’s,” the note explained, without giving details on the price of the device.

Patients considering DBS begin with consulting a movement disorder specialist, usually a neurologist, who evaluates whether their condition may benefit from this therapy. DBS follows a co-ordinated, team-based approach, with patients referred to a comprehensive DBS clinic or neurosurgery board for further assessment, it said.

Published on April 23, 2026